CY1108553T1 - Μεθοδος οξειδωσης για παρασκευη του ενδιαμεσου 6.αλφα., 9.αλφα,-διφθορο-11.βητα., 17.αλφα.-διϋδροξυ-16.αλφα.-μεθυλ.-ανδροστ-1,4-διεν-3-ονης 17.βητα καρβοξυλικου οξεος - Google Patents

Μεθοδος οξειδωσης για παρασκευη του ενδιαμεσου 6.αλφα., 9.αλφα,-διφθορο-11.βητα., 17.αλφα.-διϋδροξυ-16.αλφα.-μεθυλ.-ανδροστ-1,4-διεν-3-ονης 17.βητα καρβοξυλικου οξεος

Info

Publication number
CY1108553T1
CY1108553T1 CY20081100942T CY081100942T CY1108553T1 CY 1108553 T1 CY1108553 T1 CY 1108553T1 CY 20081100942 T CY20081100942 T CY 20081100942T CY 081100942 T CY081100942 T CY 081100942T CY 1108553 T1 CY1108553 T1 CY 1108553T1
Authority
CY
Cyprus
Prior art keywords
alpha
beta
preparation
androsten
difluoro
Prior art date
Application number
CY20081100942T
Other languages
Greek (el)
English (en)
Inventor
Frederick David Albinson
Steven John Coote
John Malcolm Robinson
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of CY1108553T1 publication Critical patent/CY1108553T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CY20081100942T 2000-07-21 2008-09-03 Μεθοδος οξειδωσης για παρασκευη του ενδιαμεσου 6.αλφα., 9.αλφα,-διφθορο-11.βητα., 17.αλφα.-διϋδροξυ-16.αλφα.-μεθυλ.-ανδροστ-1,4-διεν-3-ονης 17.βητα καρβοξυλικου οξεος CY1108553T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0017988.7A GB0017988D0 (en) 2000-07-21 2000-07-21 Novel process
EP01949791A EP1301526B1 (en) 2000-07-21 2001-07-20 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid

Publications (1)

Publication Number Publication Date
CY1108553T1 true CY1108553T1 (el) 2014-04-09

Family

ID=9896132

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100942T CY1108553T1 (el) 2000-07-21 2008-09-03 Μεθοδος οξειδωσης για παρασκευη του ενδιαμεσου 6.αλφα., 9.αλφα,-διφθορο-11.βητα., 17.αλφα.-διϋδροξυ-16.αλφα.-μεθυλ.-ανδροστ-1,4-διεν-3-ονης 17.βητα καρβοξυλικου οξεος

Country Status (26)

Country Link
US (1) US20040043974A1 (OSRAM)
EP (1) EP1301526B1 (OSRAM)
JP (1) JP2004504403A (OSRAM)
KR (1) KR100787293B1 (OSRAM)
CN (1) CN1315864C (OSRAM)
AT (1) ATE398628T1 (OSRAM)
AU (2) AU2001270906B2 (OSRAM)
BR (1) BR0110430A (OSRAM)
CA (1) CA2406963A1 (OSRAM)
CY (1) CY1108553T1 (OSRAM)
CZ (1) CZ302592B6 (OSRAM)
DE (1) DE60134472D1 (OSRAM)
DK (1) DK1301526T3 (OSRAM)
ES (1) ES2307628T3 (OSRAM)
GB (1) GB0017988D0 (OSRAM)
HK (1) HK1056179B (OSRAM)
HU (1) HUP0301108A3 (OSRAM)
IL (2) IL152348A0 (OSRAM)
MX (1) MXPA02010967A (OSRAM)
NO (1) NO324836B1 (OSRAM)
NZ (1) NZ522083A (OSRAM)
PL (1) PL206652B1 (OSRAM)
PT (1) PT1301526E (OSRAM)
SI (1) SI1301526T1 (OSRAM)
WO (1) WO2002008243A1 (OSRAM)
ZA (1) ZA200208372B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
CA2417826A1 (en) 2000-08-05 2002-02-14 Glaxo Group Limited 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
PL366937A1 (en) 2001-04-30 2005-02-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
IL150654A (en) 2002-07-09 2006-12-10 Ori Lerman Method for acid isolation 6α, 9α - difluoro - ß, 17α11 - dihydroxy - 16α - methylfargana - 3 - oxo - 1, 4 - diene - 17ß - carboxylate
US20070270584A1 (en) * 2003-04-04 2007-11-22 Trond Loevli Process for the Preparation of Steroidal Carbothioic Acid Derivatives and Intermediates
EP1466920A1 (en) * 2003-04-04 2004-10-13 Alpharma APS Process for the preparation of steroidal 17 beta-carbothioates
EP1526139A1 (en) * 2003-10-24 2005-04-27 S.N.I.F.F. Italia S.P.A. A process for preparing highly pure androstane 17-beta-carboxylic acids and androstane 17-beta-carbothioic acid fluoromethyl esters
GB0612027D0 (en) 2006-06-16 2006-07-26 Glaxo Group Ltd Novel process
NO331891B1 (no) 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
PT105139B (pt) * 2010-06-01 2013-01-29 Hovione Farmaciencia S A Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos
JP2013536835A (ja) 2010-09-01 2013-09-26 カディラ・ヘルスケア・リミテッド プロピオン酸/フロ酸フルチカゾンを調製するための方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636010A (en) * 1968-12-23 1972-01-18 Ciba Geigy Corp Esters of steroid-17-carboxylic acids
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
US4263289A (en) * 1978-04-05 1981-04-21 Syntex (U.S.A.) Inc. Thio etianic acid derivatives
US4198336A (en) * 1978-04-05 1980-04-15 Syntex (U.S.A.) Inc. Chemical process for preparing androsta-4-ene 17α-carboxylic acids
CY1291A (en) * 1980-02-15 1985-10-18 Glaxo Group Ltd Androstane 17 beta carbothioates
US5646136A (en) * 1994-01-04 1997-07-08 Duke University Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids
SI0876392T1 (en) * 1995-12-29 2000-12-31 Glaxo Group Limited Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives
US20020133032A1 (en) * 2000-02-25 2002-09-19 Jufang Barkalow Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
EP1268214B1 (en) * 2000-04-04 2006-06-07 Celanese International Corporation Ink receptive coating compositions containing poly(vinyl alcohol) grafted with amine functional groups
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions

Also Published As

Publication number Publication date
WO2002008243A1 (en) 2002-01-31
BR0110430A (pt) 2003-07-08
AU2001270906B2 (en) 2005-10-13
EP1301526A1 (en) 2003-04-16
EP1301526B1 (en) 2008-06-18
DK1301526T3 (da) 2008-10-06
NZ522083A (en) 2004-06-25
PL359462A1 (en) 2004-08-23
JP2004504403A (ja) 2004-02-12
SI1301526T1 (sl) 2008-10-31
HUP0301108A2 (hu) 2003-08-28
CN1437610A (zh) 2003-08-20
CZ20023472A3 (cs) 2003-04-16
ZA200208372B (en) 2004-02-11
PL206652B1 (pl) 2010-09-30
IL152348A0 (en) 2003-05-29
NO324836B1 (no) 2007-12-17
NO20025054L (no) 2002-11-05
CN1315864C (zh) 2007-05-16
CZ302592B6 (cs) 2011-07-27
ES2307628T3 (es) 2008-12-01
HK1056179A1 (en) 2004-02-06
MXPA02010967A (es) 2003-03-27
HK1056179B (en) 2009-07-17
KR100787293B1 (ko) 2007-12-20
IL152348A (en) 2008-08-07
CA2406963A1 (en) 2002-01-31
PT1301526E (pt) 2008-09-09
AU7090601A (en) 2002-02-05
US20040043974A1 (en) 2004-03-04
KR20030028736A (ko) 2003-04-10
HUP0301108A3 (en) 2008-04-28
NO20025054D0 (no) 2002-10-21
ATE398628T1 (de) 2008-07-15
GB0017988D0 (en) 2000-09-13
DE60134472D1 (de) 2008-07-31

Similar Documents

Publication Publication Date Title
CY1108553T1 (el) Μεθοδος οξειδωσης για παρασκευη του ενδιαμεσου 6.αλφα., 9.αλφα,-διφθορο-11.βητα., 17.αλφα.-διϋδροξυ-16.αλφα.-μεθυλ.-ανδροστ-1,4-διεν-3-ονης 17.βητα καρβοξυλικου οξεος
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
CY2008009I2 (el) 6.αλφα., 9.αλφα. - διφθορο-17.αλφα.-(2-φουρανυλοανθρακοξυλικο) οξυ-11.βητα.-υδροξυ-16.αλφα.-μεθυλο-3-οξο-ανδροστα-1,4-διενιο-17-ανθρακοθειικο οξυ s-φθορομεθυλο εστερας ως αντιφλεγμονωδης παραγοντας
CY1108931T1 (el) Μεθοδος παρασκευης παραγωγων βενζιμιδαζολ-2-υλο-κινολινονης
BR0314227A (pt) Derivados de amido de hidroxialquila
EA200300065A1 (ru) Окисленные сложные эфиры 4-йодфениламинобензгидроксамовых кислот
CY1106598T1 (el) Παραγωγα κινολινης και ισοκινολινης, μεθοδος για την παραγωγη αυτων και χρηση αυτων ως αντιφλεγμονωδη μεσα
PT1627880E (pt) Compostos de ácido e éster borónico, sínteses e utilizações
CY1106076T1 (el) Παραγωγα γλυκοπυρανοσυλοξυβενζυλο βενζολιου και ιατρικες συνθεσεις που πepιεχουν τα ιδια
BR0009762A (pt) Catalisador para produção de ácido acético ou ácido acético e acetato de etila, processo para sua produção e processo para produção de ácido acético ou ácido acético e acetato de etila usando-o
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
ATE239751T1 (de) 9-hydrazon- und 9-azynerythromycinderivate und verfahren zu deren herstellung
DK1255795T3 (da) Klæbriggörende polyester og klæbemiddelsammensætning
ES2159919T3 (es) Procedimiento para la preparacion de compuestos de tipo ceramidas.
BR0109048A (pt) Processo para a sìntese de citalopram
DE69920923D1 (de) Anthranilsäurederivate
FI942457A0 (fi) Substituoitujen piperidiinien valmistus
DK0719250T3 (da) Syntese af amidosyrer ud fra carboxylsyrer og lactamer
TR199800543A2 (xx) Benziloksi ikame edilen, aniliye edilmi� N-heterosiklik bile�ikler.
NO20023276D0 (no) Fremgangsmåte til å fremstille betulinsyre
ATE367374T1 (de) Sulphonsäurederivate von hydroxamsäuren und deren verwendung in medizinischen produkten
CY1107937T1 (el) Προφαρμακα σε συνδετες υποδοχεα nmda
ATE324366T1 (de) Verfahren zur herstellung von 3-pyrrolin-2- carbonsäure-derivaten
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
ATE349545T1 (de) Enzymatisches verfahren zur herstellung von substituierter 2-amino-3-(2-amino-phenylsulfanyl)-propionsäure